Literature DB >> 28899208

The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism.

Sae Bom Lee1, Brianna N Sellers1, Gina M DeNicola1.   

Abstract

SIGNIFICANCE: The stress responsive transcription factor nuclear factor erythroid 2 p45-related factor 2, or NRF2, regulates the expression of many cytoprotective enzymes to mitigate oxidative stress under physiological conditions. NRF2 is activated in response to oxidative stress, growth factor signaling, and changes in nutrient status. In addition, somatic mutations that disrupt the interaction between NRF2 and its negative regulator Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated 1 (KEAP1) commonly occur in cancer and are thought to promote tumorigenesis. Recent Advances: While it is well established that aberrant NRF2 activation results in enhanced antioxidant capacity in cancer cells, recent exciting findings demonstrate a role for NRF2-mediated metabolic deregulation that supports cancer cell proliferation. CRITICAL ISSUES: In this review, we describe how the NRF2-KEAP1 signaling pathway is altered in cancer, how NRF2 is regulated by changes in cellular metabolism, and how NRF2 reprograms cellular metabolism to support proliferation. FUTURE DIRECTIONS: Future studies will delineate the NRF2-regulated processes critical for metabolic adaptation to nutrient availability, cellular proliferation, and tumorigenesis. Antioxid. Redox Signal. 00, 000-000.

Entities:  

Keywords:  KEAP1; NRF2; cysteine; glycine; metabolism; serine

Mesh:

Substances:

Year:  2017        PMID: 28899208     DOI: 10.1089/ars.2017.7356

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  22 in total

1.  Heme oxygenase promotes B-Raf-dependent melanosphere formation.

Authors:  Kimberly J Jasmer; Jie Hou; Philip Mannino; Jianlin Cheng; Mark Hannink
Journal:  Pigment Cell Melanoma Res       Date:  2020-07-09       Impact factor: 4.693

Review 2.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

3.  Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis.

Authors:  Di Zhang; Ana S Leal; Fawzi Abu Rous; Karen T Liby
Journal:  Ann Transl Med       Date:  2019-07

4.  Increased O-GlcNAcylation of SNAP29 Drives Arsenic-Induced Autophagic Dysfunction.

Authors:  Matthew Dodson; Pengfei Liu; Tao Jiang; Andrew J Ambrose; Gang Luo; Montserrat Rojo de la Vega; Aram B Cholanians; Pak Kin Wong; Eli Chapman; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2018-05-15       Impact factor: 4.272

5.  Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition.

Authors:  Xiangcui Chen; Qipeng Wu; Yueming Chen; Jiahao Zhang; Huachao Li; Zhicheng Yang; Yang Yang; Yanchao Deng; Luyong Zhang; Bing Liu
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

6.  Spermidine Confers Liver Protection by Enhancing NRF2 Signaling Through a MAP1S-Mediated Noncanonical Mechanism.

Authors:  Pengfei Liu; Montserrat Rojo de la Vega; Matthew Dodson; Fei Yue; Boyun Shi; Deyu Fang; Eli Chapman; Leyuan Liu; Donna D Zhang
Journal:  Hepatology       Date:  2019-05-20       Impact factor: 17.425

Review 7.  Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Authors:  Elvira Pelosi; Germana Castelli; Ugo Testa
Journal:  Biomedicines       Date:  2017-11-18

Review 8.  "Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.

Authors:  Sarah A Best; Kate D Sutherland
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

9.  NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.

Authors:  Etay Ziv; Yiru Zhang; Luke Kelly; Ines Nikolovski; F Edward Boas; Joseph P Erinjeri; Liqun Cai; Elena N Petre; Lynn A Brody; Anne M Covey; George Getrajdman; James J Harding; Constantinos Sofocleous; Ghassan K Abou-Alfa; Stephen B Solomon; Karen T Brown; Hooman Yarmohammadi
Journal:  Radiology       Date:  2020-08-11       Impact factor: 11.105

10.  KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.

Authors:  Pranavi Koppula; Kellen Olszewski; Yilei Zhang; Lavanya Kondiparthi; Xiaoguang Liu; Guang Lei; Molina Das; Bingliang Fang; Masha V Poyurovsky; Boyi Gan
Journal:  iScience       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.